QualityStocksNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Raises $13M for Rapid Expansion of Investor Intelligence, Data Analytics and Communications Platform

SRAX (NASDAQ: SRAX), a digital marketing and consumer data management technology company, today announced its entry into definitive securities purchase agreements led by existing institutional investors for the purchase and sale of an aggregate of $13 million senior secured convertible debentures at an above market fixed conversion price of $2.69. According to the update, the Company intends to use the proceeds to fund the rapid expansion of its investor intelligence, data analytics and communications platform, Sequire.

To view the full press release, visit http://ibn.fm/riIuX

About SRAX
SRAX (NASDAQ: SRAX) is a digital marketing and consumer data management technology company. SRAX’s technology unlocks data for brands in the CPG, investor relations, luxury, and lifestyle verticals. Through its various platforms, SRAX is monetizing its data sets and growing multiple recurring revenue streams. BIGtoken is a consumer-managed data marketplace where people can own and earn from their data. The platform also provides advertisers and media companies access to transparent, verified consumer data to better reach and serve audiences. Sequire is a premier platform for investor intelligence and communication. Through Sequire, public companies can track their investors’ behaviors and trends and use those insights to engage current and potential investors across marketing channels. For more information on SRAX and its verticals, visit www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) to Access Extensive Lease Financing for Its Auto-Trading Platform Users

-Company subsidiary MUSA Auto Finance, LLC will enable consumers and dealers to access extensive funding facilities from national financial institutions through the platform
-The lease originations are expected to allow users to acquire virtually any vehicle from any location via a smart phone or other digital devices
MUSA will also make PowerBand’s auto trading platform available to thousands of dealerships that work with RouteOne, LLC across Canada and the U.S.
-PowerBand Solutions’ cloud-based platform offers users transparency and complete control over the purchasing process by streamlining the interactions among all participants and eliminating unnecessary middlemen

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (Frankfurt: 1ZVA) is expected to begin lease originations in June on its proprietary cloud-based platform for consumers and auto dealers. The company plans to access this extensive lease financing via subsidiary MUSA Auto Finance, LLC, which operates PowerBand’s 60 percent controlled leasing platform in the U.S., according to a company press release (http://ibn.fm/Lha50).

Developed by a team of experienced automotive, technology and finance experts, PowerBand Solutions’ platform empowers the consumer to self-direct a transaction, by streamlining the interactions among all participants and eliminating unnecessary middlemen. The platform allows consumers to sell, buy, lease, auction and finance vehicles with never-seen-before simplicity, speed and cost-efficiency from their smart phones or other devices, irrespective of their location. PowerBand’s platform benefits key stakeholders in the automotive retail sector, including funders, OEMs and rental companies, by removing unnecessary third parties and their fees from sales transactions.

Via MUSA, users of the platform will be able to access extensive funding opportunities from national financial institutions. Upon completion of these financial arrangements, consumers and auto dealers will be able to view details about the financing arrangements on smart phones and other digital devices.

PowerBand’s CEO Kelly Jennings anticipates the platform will be originating significant lease contracts for consumers and dealers that he said will “enable people to acquire just about any vehicle – electric and non-electric – from any location using a smart phone or other digital device.”

In addition, MUSA has agreed to make PowerBand’s platform available to thousands of dealerships in the United States and Canada that work with RouteOne, LLC and its network of more than 16,000 automotive dealers and 1,500 finance sources. MUSA will continue other ongoing negotiations to promote the availability of credit facilities on the PowerBand platform as it strives to become a global leader in providing online transactions for the industry.

PowerBand aims to modernize the automotive industry by providing dealers and consumers with the most advanced digital leasing alternatives in the market. The MUSA technology can take an application, calculate the lease, auto-decision the application, provide approvals to dealer partners and accurately prefill lease contracts. The entire process happens in just a few seconds. The technology earned MUSA a contract with Tesla Motors as a leasing partner in 2018.

The automotive industry market has been in a state of flux, with every aspect experiencing disruption from driverless vehicles to artificial intelligence. Customer expectations for the market have been raised as technological innovations progress. As more customers begin to expect the same seamless and fast digital services they receive in other retail markets, the automotive industry must adapt to remain competitive and protect profits as well as finance and insurance margins. To do so, retailers must find opportunities to leverage the digital trend consumers demand and their desire for advanced technology.

PowerBand is positioned to capitalize on these trends by disrupting the antiquated business model of the automotive industry, replacing distrust and confusion with transparency, access to information and ease of use.

For more information, visit the company’s website at www.PowerBandSolutions.com.

NOTE TO INVESTORS: The latest news and updates relating to PWWBF are available in the company’s newsroom at http://ibn.fm/PWWBF

QualityStocksNewsBreaks – CloudCommerce, Inc. (CLWD) Signs New Client – Desert Mountain – to Help Drive Club Membership, Home Sales

CloudCommerce (OTC: CLWD), a leading provider of digital advertising solutions, today announced that it signed a new client, Desert Mountain, to help them increase club membership and home sales. According to the update, the agreement calls for a multi-phase approach beginning with audience data discovery and analysis, followed by creation of several custom video and static ad concepts culminating with a highly targeted digital advertising strategy. “We have been looking to consolidate all of the capabilities needed to execute a data-driven marketing strategy under one roof,” Kim Atkinson, Director of Marketing and Communications at Desert Mountain, said in the news release. “CloudCommerce’s solution fits our needs perfectly. We’re off to an exciting start.”

To view the full press release, visit http://ibn.fm/cIbWA

About Cloud Commerce, Inc.
CloudCommerce, Inc. (CLWD) is a leading provider of digital advertising solutions. Its flagship solution, SWARM, analyzes a robust mix of audience data to help businesses find who to talk to, what to say to them, and how to market to them. CloudCommerce does this by applying advanced data science, behavioral science, artificial intelligence, and market research techniques to discover, develop and create custom audiences for highly targeted digital marketing campaigns. CloudCommerce was Ranked Number 235th Fastest Growing Company in North America on Deloitte’s 2019 Technology Fast 500(TM). To learn more about CloudCommerce, please visit www.CloudCommerce.com

NOTE TO INVESTORS: The latest news and updates relating to CLWD are available in the company’s newsroom at http://ibn.fm/CLWD

The Movie Studio, Inc. (MVES) Benefits from Explosion in Original Content Programming

-The Movie Studio has benefitted from recent surge in demand for VOD platforms
-Launch of new streaming platforms has led to increase in demand for original content, product differentiation
-44% of viewers are now opting to view original content unique to specific platform
-MVES has monetized its film assets across a number of VOD providers and recently expanded its distribution to foreign markets

As theaters have been shuttered across the world in the wake of COVID-19, movie studios have had to find ways to reach moviegoers at home—a move that has created a windfall for video-on-demand (“VOD”) purveyors. Original content and film producers such as The Movie Studio (OTC: MVES) have been major beneficiaries of the recent surge in demand for online content.

AMC Theaters, the world’s largest cineplex operator, recently announced that “almost all” of its locations in the United States and Britain would reopen by July (http://ibn.fm/J7Ayd). The dearth of cinematic content as well as the lengthy lock-downs prompted by the COVID-19 pandemic has led to an explosion in growth for VOD platforms, with up to 12,000 consumers a day reportedly cutting ties with their traditional satellite and cable service in favor of online platform subscriptions (http://ibn.fm/Zt6z3).

In April 2020, Netflix released its first quarter results, revealing that the streaming platform had added 15.8 million new subscribers in the first quarter of the year – up 23% year over year and, remarkably, over double the 7 million new subscribers the company had originally forecast (http://ibn.fm/bDgX9). However, the launch of a spate of new streaming platforms – including the likes of Apple TV+, Disney, Comcast’s NBCU and AT&T’s WarnerMedia, and the growing need for product differentiation has led to a rising demand for original content programming.

A 2019 study by consultancy PwC found that video-on-demand VOD viewers spent 44% of their time watching content which was original to the platform it was viewed on (http://ibn.fm/M7amL). The rise in competition as well as the difficulty in sourcing licensed content has led to a surge of investment in to original content creation. Netflix alone is forecast to spend $17.8 billion on original content production in 2020, a 157% increase on its spend only five years prior (http://ibn.fm/d8iKr).

A beneficiary of the growing need of streaming platforms to secure original content, The Movie Studio has sought to carve out a niche for its unique brand of films by creating and distributing its content on major subscription VOD platforms without the expense of using recognizable movie stars; the strategy in turn has allowed the company to focus on increasing production quality and reduced its overall capital expenditure.

Thus far the company has successfully monetized its film assets on platforms such as Amazon Prime, tubi tv, Comcast and Showtime while entering into a number of distribution agreements to further bolster its commercial efforts going forward. In addition to its existing partnership with Filmhub for the licensing and distribution of its motion pictures, The Movie Studio recently announced that it had entered into a memorandum of understanding with BINGE Networks LLC, an award-winning streaming platform which has enabled MVES to syndicate and monetize its content globally.

“We are excited to leverage a digital platform for our current and future aggregated titles and to facilitate title recognition for upcoming movies,” stated The Movie Studio president and CEO Gordon Scott Venters. “This platform allows for geo-fracturing of worldwide distribution rights, isolating our potential revenue streams and allowing for the maximization and monetization of intellectual property rights” (http://ibn.fm/jOhv5). Venters went on to elaborate on the recent monetization efforts achieved through its collaboration with BINGE Networks, “We also recently announced that The Movie Studio has licensed several films, including ‘Bad Actress’ and ‘Exposure’ for distribution in Australia.” (http://ibn.fm/9qLmW).

With worldwide subscribers expected to top 1.1 billion by 2021 (http://ibn.fm/s1GMl), the global growth of VOD platform revenue is expected to rise from $69 billion in 2018 to $129 billion by 2023 (http://ibn.fm/y5dWg). The Movie Studio’s innovative distribution model, vast film library and wide array of feature films in pre-production has optimally positioned the company to capitalize on the continued surge in global demand for original content programming going forward.

For more information, visit the company’s website at www.TheMovieStudio.com.

NOTE TO INVESTORS: The latest news and updates relating to MVES are available in the company’s newsroom at http://ibn.fm/MVES

QualityStocksNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Announces Amendment to Securities and Shares for Debt

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF), an integrated oil ?company focused on the development and implementation of its proprietary oil-?extraction and remediation technologies, on Wednesday announced the amendment of three convertible debentures and three warrants issued to an arm’s length lender between July 2019 and October 2019. According to the update, the parties to the agreement intend to amend the conversion price applicable to the purchase price (US$650,000) of the US$780,000 principal amount convertible debentures from US$0.17, US$0.19 and US$0.21 to US$0.037. In addition, the parties intend to amend the exercise price of three warrants issued to the lender exercisable for up to 3,444,639 common shares of the Company from US$0.20, US$0.24 and US$0.26 to US$0.03. These and additional transactions as detailed in the news release are subject to approval of the TSX Venture Exchange.

To view the full press release, visit http://ibn.fm/1WBnm

About Petroteq Energy Inc.
Petroteq is a fully integrated clean technology company focused on the development and implementation of a new proprietary technology for oil extraction. The Company has an environmentally safe and sustainable technology for the extraction and reclamation of heavy and bitumen from oil sands, oil shale deposits and shallow oil deposits. Petroteq is engaged in the development and implementation of its patented environmentally friendly heavy oil processing and extraction technologies. Petroteq is currently focused on developing its oil sands resources and expanding production capacity at its Asphalt Ridge soil remediation and heavy oil extraction processing facility located near Vernal, Utah.

For more information, visit www.Petroteq.energy.

NOTE TO INVESTORS: The latest news and updates relating to PQEFF are available in the company’s newsroom at http://ibn.fm/PQEFF

QualityStocksNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) to Participate Live on “The Big Biz Show”

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes, today announced that its CEO and Chairman, Rodney Varner, will be participating in a live interview with the “Big Biz Show,” an Emmy Award winning nationally syndicated TV and radio show, on Thursday, June 25. The Big Biz Show, seen and heard in over 100 million broadcast TV homes, 150 U.S. radio stations and in 175 countries, covers current business events, internet-related issues and other hot topics in the business world. Among several engaging topics, Varner will discuss how Genprex is bridging critical gaps in modern medicine by providing new treatment options to patients with cancer and diabetes

To view the full press release, visit http://ibn.fm/wLETO

About Genprex, Inc.
Genprex, Inc. is a clinical-stage gene therapy company developing potentially life-changing technologies for patients with cancer and diabetes. Genprex’s technologies are designed to administer disease-fighting genes to provide new treatment options for large patient populations with cancer and diabetes who currently have limited treatment options. Genprex works with world-class institutions and collaborators to in-license and develop drug candidates to further its pipeline of gene therapies in order to provide novel treatment approaches. The Company’s lead product candidate, Oncoprex(TM), is being evaluated as a treatment for non-small cell lung cancer (“NSCLC”). Oncoprex has a multimodal mechanism of action that has been shown to interrupt cell signaling pathways that cause replication and proliferation of cancer cells; re-establish pathways for apoptosis, or programmed cell death, in cancer cells; and modulate the immune response against cancer cells. Oncoprex has also been shown to block mechanisms that create drug resistance. In January 2020, the U.S. Food and Drug Administration granted Fast Track Designation for Oncoprex immunogene therapy for NSCLC in combination therapy with osimertinib (AstraZeneca’s Tagrisso(R)) for patients with EFGR mutations whose tumors progressed after treatment with osimertinib alone. For more information, please visit the company’s website at www.Genprex.com

NOTE TO INVESTORS: The latest news and updates relating to GNPX are available in the company’s newsroom at http://ibn.fm/GNPX

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives Two Purchase Orders Valued at $625K from Leading Distributor

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), today announced its receipt of two purchase orders valued at $625,000 from a leading distributor servicing U.S. Tier 1 cellular operators. According to the update, the orders are for Siyata’s Uniden(R) UV350 4G/LTE in-vehicle device and additional accessories. “Growing our sales in the U.S. remains the primary focus for Siyata this year, and we are very pleased to announce this purchase order coming from a leading distributor working with major cellular carriers,” Marc Seelenfreund, CEO of Siyata Mobile, stated in the news release.

To view the full press release, visit http://ibn.fm/j5fjB

About Siyata
Siyata Mobile Inc. is a B2B global vendor of next generation Push-To-Talk over Cellular (“PTT”) devices and cellular booster systems. Its portfolio of in-vehicle and rugged smartphones enable first responders and enterprise workers to instantly communicate, over a nationwide cellular network of choice, to improve communication, increase situational awareness and save lives.
Its portfolio of enterprise cellular booster systems enables first responders and enterprise workers to amplify cellular signal in remote areas, inside structural buildings where signals are weak and within vehicles for maximum cellular signal strength possible.
Visit www.SiyataMobile.com and www.UnidenCellular.com to learn more.

NOTE TO INVESTORS: The latest news and updates relating to SYATF are available in the company’s newsroom at http://ibn.fm/SYATF

ISW Holdings (ISWH) Enters Crypto Space via Partnership with Leading Crypto Mining Company

-Joint venture with Bit5ive represents milestone for ISWH as it marks company’s first foray into burgeoning crypto world.
-ISWH excited to expand current portfolio, move into sector poised for strong technological and financial growth.
-ISW Holdings among limited, exclusive options for equity market investors looking to capitalize.

International Spirits & Wellness Holdings (OTC: ISWH) (“ISW Holdings”), a global brand-management holdings company, has entered the cryptocurrency space via a joint agreement with Bit5ive, an official distributor of top-selling crypto mining equipment (http://ibn.fm/Fb1E8). The joint venture represents a milestone moment for ISWH as it marks the company’s first foray into a burgeoning crypto world, where the Bitcoin technology market, valued at more than $293 million in 2019, is expected to reach $477 million by 2025.

The move appears to be a strong strategic one for ISWH, which has growing businesses in multiple sectors, including renewable energy, home health care, wellness and restoration, the adult beverage industry, and operations in supply chain and logistics management. “We are incredibly excited to expand our current portfolio and move into what we believe is a sector poised for strong technological and financial growth,” said ISWH president and chairman Alonzo Pierce (http://ibn.fm/SYUp7). “This new joint-venture agreement enables us to collaborate with the experienced team at Bit5ive to innovate the infrastructure needed to run profitable, efficient crypto mining projects and to take advantage of the incredible growth projected for the crypto market.”

The explosive potential of cryptocurrency mining should only strengthen the company’s already diverse portfolio, making it even more attractive to investors. In fact, a recent “Journal Transcript” article, titled “ISWH and Bit5ive Team Up to Conquer the Crypto Mining Capex Opportunity,” noted that “for traders and investors in the equities markets, one theme has remained extremely difficult to find in terms of portfolio exposure: cryptocurrency mining. Very few companies have genuine exposure and constructing a diversified portfolio of equities with operational ties to the crypto mining theme has remained an elusive goal. . . . But, as a result of a groundbreaking new joint venture announcement that hit the newswires in May, ISWH is now one of the most interesting new vehicles through which investors can gain exposure to the cryptocurrency capital equipment marketplace.”

As ISWH enters this growing sector, Bit5ive looks to be the ideal partner. The new partnership draws on strengths of both parties to combine global brand management with innovative crypto mining solutions.
Bit5ive is an official distribution partner of Bitmain, the industry-leading fabless manufacturer of computing chips and distributor of Antminers to more than 30 countries in Latin America, Central America, and the Caribbean. In addition, Bit5ive produces and distributes POD5 and Power Skid 2.5, recognized as the most efficient and successful infrastructure for crypto mining hardware. Bit5ive is one of the largest U.S.-based companies in the cryptocurrency mining and bitcoin farm industry, a clear an indication of increased interest in bitcoin and blockchain technologies.

“We have achieved considerable growth and hit several major milestones in the last three years, consistently growing our staff and honing our expertise along the way,” said Bit5ive CEO Robert Collazo. “It is important that we continue innovating and be over par with industry demand from every aspect.”

This new partnership should allow both companies to do exactly that. “There are very few stocks in the stock market with genuine exposure to the upside in cryptocurrency mining,” the “Journal Transcript” article concluded. “As the mining space expands in response to more demand for coins, mining equipment is likely to become a core investment theme. And now, following its partnership with Bit5ive, ISW Holdings Inc. is among a very limited and exclusive set of options for equity market investors looking to capitalize.”

For more information, visit the company’s website at www.ISWHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH

QualityStocksNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) Achieves Continued Robust Growth, on Pace for Record Month

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced continued robust growth in total volume of cannabis sales and revenues from cannabis sales during the month of June, which is now on pace to set a new Company performance record. “We continue to benefit from our decision in March to get more aggressive rather than retrench in response to the coronavirus crisis,” Simon Yu, CEO of Cannabis Strategic Ventures, stated in the news release. “The cannabis shortage we have seen in California since that time has afforded us a golden opportunity to sharply expand our distribution footprint and nurture a widening network of key distributor relationships. June is on pace to be our third consecutive record sales month. Given our strong positioning and expanding production capacity, we anticipate continued robust growth ahead.”

To view the full press release, visit http://ibn.fm/GBiIm

About Cannabis Strategic Ventures
Cannabis Strategic Ventures Inc. (OTC: NUGS) is one of the largest publicly traded marijuana cultivators in the United States. The Company is Los Angeles-based and incubates, develops and partners with category leaders within the cannabis and ancillary sectors. The Firm’s NUGS brand experience provides operational and financial strategic partnerships and a range of essential services to emerging and existing cannabis consumer brands. For more information, visit www.CannabisStrategic.com.

NOTE TO INVESTORS: The latest news and updates relating to NUGS are available in the company’s newsroom at http://ibn.fm/NUGS

Vivos Therapeutics, Inc. Launches Promising Treatment of Mild to Moderate Obstructive Sleep Apnea in Adults

-Obstructive Sleep Apnea (“OSA”) impacts up to 1 billion people globally, including 54 million Americans
-Estimates suggest OSA costs the U.S. economy $165 billion annually
-Vivos System offers significant advantages over traditional OSA treatment approaches
-Over 4,300 healthcare professionals registered for Vivos’ education and training Summit in March 2020, with strong and growing interest in this disruptive new technology

Vivos Therapeutics’ Vivos System is the first treatment modality for mild to moderate OSA based on the ability to remodel and enhance the function, size, and shape of the human airway, in most cases avoiding the need for lifelong interventions. The system’s treatment time is a fraction of that of its alternatives, potentially relieving symptoms in a matter of 18-24 months in most cases without the need for surgery (http://ibn.fm/7opjM).

The company’s existing mRNA (Mandibular Repositioning Appliance) is an FDA cleared class II device that treats mild to moderate sleep apnea, snoring, and sleep disordered breathing in adults. This is great news for people suffering from sleep apnea, as the device for most patients can serve as a potential lasting solution to these frustrating and dangerous conditions. It is estimated that OSA affects approximately 1 billion people worldwide, of which 54 million are Americans (http://ibn.fm/jrHQ6).

Vivos created and patented its novel system to combat OSA caused by deficiencies and other tissue anomalies in craniofacial anatomy development, the main cause of 98% of OSA cases. The multidisciplinary treatment protocol is comprised of comfortable and customized oral devices as well as biofunctional therapies, such as training the tongue. Over the course of treatment, the patient’s upper airway is effectively increased and enhanced, reducing tissue obstructions causing OSA. Vivos’ technology represents the first true hope of an effective OSA solution not involving surgery or lifelong interventions (http://ibn.fm/SuE6g).

The company is also developing an mmRNA (Modified Mandibular Repositioning Appliance) device, which is currently undergoing mechanical testing. Once this has been completed, the company plans to submit a 510k to the FDA for class II clearance approval. Once they have the FDA’s 510k clearance and award letter, they will approach Medicare in hopes to have the mmRNA added to the PDAC approved oral devices to treat mild to moderate sleep apnea, snoring, and sleep disordered breathing in adults. If Medicare provides Vivos CMS PDAC approval, they can bill the mmRNA for adults 65 and up with Medicare and/or adults 18 and up with various commercial policies that do follow Medicare guidelines.

Although Vivos devices are currently cleared only for mild to moderate sleep apnea in adults, and not for severe sleep apnea, the company believes its technology represents the most important breakthrough in OSA treatment since CPAP (Continuous Positive Airway Pressure), which involves the continuous use of special face or nasal masks.

Vivos’ proprietary system is designed to promote correct growth and development of the hard and soft tissues surrounding and compromising the oral cavity, nasal cavity, upper and lower jaws, and other tissues which comprise and shape the human airway. The system uses Pneumopedics(R), the natural process induced by Vivos biomimetic technology to widen and expand the patient’s airway, allowing for proper breathing through the nose. This addresses the root cause of OSA effectively.

The Vivos System multidisciplinary treatment protocol involves collaboration between physicians, dentists who have completed advanced training in craniofacial sleep medicine, and other ancillary healthcare providers. Unlike many other approaches, it aims for a lasting resolution by targeting the root cause of sleep apnea. Vivos clinicians can now be found in almost every major city in the U.S. and in many countries.

Vivos sponsored its first online education and training Summit on March of 2020, featuring selected clinicians from the dental and medical arena. The event reached maximum capacity in just three days, with over 500 dentists in attendance. Six additional two-day encore events were quickly scheduled twice a week thereafter to accommodate the surging demand. Over 4,300 healthcare professionals concerned about sleep, breathing, and wellness, are currently registered for the innovative program (http://ibn.fm/dM8CQ).

“By going virtual with sleep/breathing education and training, we have created an opportunity for everyone to come and learn about the latest developments in currently available treatment options,” said Vivos Co-Founder and CEO R. Kirk Huntsman. ” We believe our approach and related services could make a huge difference in the lives of many.”

For more information, visit the company’s website at www.VivosLife.com

NOTE TO INVESTORS: The latest news and updates relating to Vivos Therapeutics are available in the company’s newsroom at http://ibn.fm/VVOS

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Appoints New VP to Develop Business Opportunities, Identify Potential Strategic Partners

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced the appointment of seasoned executive Alain Charlois as Vice President of Strategic Partnerships, effective July 1, 2020. Charlois will be responsible for developing new business opportunities and identifying potential strategic partners in the Advanced Driver Assistance Systems (“ADAS”) and autonomous driving markets in North America and Europe. “Foresight’s unique vision technology has the potential to revolutionize automotive safety” Haim Siboni, Foresight’s CEO, said in the news release. “Mr. Charlois’ unique skills and extensive industry relationships will allow us to generate additional interest in our offerings, help us identify and connect with potential corporate partners, and expand our presence in the ADAS and autonomous vehicles markets.”

To view the full press release, visit http://ibn.fm/ckH7f

About Foresight
Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of sight” vision systems and “beyond-line-of-sight” cellular-based applications. Foresight’s vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. Eye-Net Mobile’s cellular-based application is a V2X (vehicle-to-everything) accident prevention solution based on real-time spatial analysis of clients’ movement.

The company’s systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the semi-autonomous and autonomous vehicle markets and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost effective platform and advanced technology.

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.ForesightAuto.com

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

Kingman Minerals Ltd. (TSX.V: KGS) Ideally Positioned as Investors Seek ‘Safe-Haven’ Assets

-Gold prices have gained 15% so far this year, surpassing $1,700 per ounce threshold.
-Yahoo Finance article concludes that gold will continue to be preferred investment option.
-KGS is dedicated to acquisition, exploration and development of gold, silver properties in North America

As the economy struggles to regain stability in the fragile environment created by a global pandemic, gold has emerged as a highly preferred investment option. The precious metal has long been recognized for being one of the most consistently performing investments over time, a fact that puts Kingman Minerals (TSX.V: KGS) in an attractive position for those looking for an investment foothold in the gold or silver industry.
“Gold prices have gained 15% so far this year and surpassed the $1,700 an ounce threshold for the first time in seven years,” a recent Yahoo Finance article reported (http://ibn.fm/xFmr6). “This was primarily driven by the coronavirus-induced crisis that triggered apprehensions regarding the global economic growth. This, in turn, sent investors scurrying for safe-haven assets like gold.

“The Fed has slashed interest rates to zero,” the article continued. “Notably, lower the interest rates, lesser will be the opportunity cost of holding non-yielding bullion, making gold an attractive option for investors holding other currencies. Further, lower oil prices and fears of supply crunch with miners halting their operations as per government mandates to stem the coronavirus spread have also contributed to the price movement. Further, mining companies are major consumers of energy with around 50% of their production costs closely linked to energy prices. The current combination of higher gold prices and lower oil prices will translate into improved operating margins and higher free cash flow for miners.”

The Yahoo article, titled “Gold Mining Stocks’ Outlook Bright on Coronavirus Fears,” noted that, because of COVID-19, the global economy has been upended, resulting in gold seeing its best performance since 2010, increasing as much as 20%, with analysts predicting a continued increase. Calling gold a “safe-haven asset,” the article concluded by stating, “Gold will continue to be the preferred investment option supported by the environment of low interest rates and coronavirus-induced global slowdown. Lower mined gold supply, higher demand and geopolitical tensions are likely to drive prices north, which bodes well for gold-miners.”

With two current mining operations in place — the Mohave Project and the Cadillac East Property — Kingman Minerals appears ideally positioned in today’s volatile investment world. KGS is focused on sourcing and developing high-quality, nongrass-roots properties in favorable mining jurisdictions, and has entered into option agreements to purchase 100% of the properties within its portfolio.

Kingman’s Mohave Project is located in the Music Mountains in Mohave County, Arizona, and is comprised of 20 lode claims, including those from the Rosebud Mine. In addition, KGS has entered into an option agreement with two arms’ length vendors to acquire a 100% interest in 52 nearby lode claims covering an area of 1,071.2 acres. High-grade gold and silver veins were discovered in the area in the 1880’s and were mined into the late ‘20s and ‘30s.

The company’s Cadillac East Property is located east of Val d’Or, a hub for exploration and mining activities in the Canadian province of Quebec. The property consists of 12 claims, and KGS has an option agreement to earn 100% over three years. Recent exploration reported multiple potential targets for future investigation, as results from the soil program identified value in gold, silver, copper, zinc and nickel.
Formerly known as Astorius Resources Ltd., Kingman Minerals is engaged in the acquisition, exploration and development of gold and silver properties in North America. Based in Canada, KGS is focused on sourcing and developing high-quality properties with significant mining potential as part of its strategy of developing a diverse portfolio of low-cost, lifelong assets.

For more information, visit the company’s website at www.KingmanMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to KGS are available in the company’s newsroom at http://ibn.fm/KGS

Trxade Group, Inc. (NASDAQ: MEDS) Brings Taglich Brothers Onboard to Build Brand Reporting, Welcomes New Bonum Health President

-Trxade Group Inc. is a growing B2B pharmaceutical network that provides solutions to small healthcare businesses, care providers and medical patients through growing optimization of remote-access health services
-Amid the sweep of the global COVID-19 pandemic, Trxade Group has continued to build its vision of enabling the health industry to operate transparently and effectively even as the importance of changing remote-access medicine models grows
-Trxade Group recently began receiving research report coverage from investment services firm Taglich Brothers, Inc. as part of ongoing brand-building efforts
-The company also recently announced that experienced healthcare market advisory professional Ashton Maaraba has been named president of Trxade Group’s Bonum Health telemedicine practice and will guide new patient acquisition

Growing prescription drug delivery and healthcare services innovator Trxade Group (NASDAQ: MEDS) continues to nurture a brand built on the vision of officers intent on providing affordability, transparency and equal access to medical community patients through effective technology. The company recently announced that investment services firm Taglich Brothers, Inc. has begun providing coverage to Trxade through its research division (http://ibn.fm/sSOt8).

Trxade’s efforts to expand its network of independent pharmacies and empower them to better deliver medications regardless of competition from larger retail chains have resulted in an upswell of brand-building and marketing outreach during the past several months.

After Trxade’s acquisition of Internet drug outlet company Community Specialty Pharmacy, LLC, (http://ibn.fm/wrNq4) the company began building a remote-access “secure virtual examination room” for patient-physician consultation through a “Health Hub” initiative that partners with the company’s drug delivery services (http://ibn.fm/3mHKC).

Trxade then began listing its common stock on The NASDAQ Capital Market in February as part of its efforts to increase its visibility, stability and ability to attract new investment (http://ibn.fm/uTO4r), even as the novel coronavirus pandemic was beginning to make itself known throughout the world. Trxade helped respond to concerns about limited testing for the new virus by rolling out an FDA-approved rapid point-of-care skin prick test to help medical professionals triage patients with potential COVID symptoms (http://ibn.fm/0Oknn).

Trxade’s developments are helping to position the company to deliver value to the health care market in coming days as nations recover from their initial shock at seeing populations decimated by the pandemic and begin working with confidence on providing health solutions and solutions that address economic and lifestyle needs.

“We believe our platform will become even more important for our customers in the years to come. We have a clear vision of our strategy and the opportunities ahead and look forward to another successful year of growth,” Board Chairman and CEO Suren Ajjarapu stated earlier this year in a report on the company’s 2019 achievements (http://ibn.fm/jA8tM).

The Taglich Brothers coverage involves an agreement for Taglich to create and disseminate research reports on Trxade and its market. Trxade has paid for the initial two months, which will begin reporting in September, and will begin paying a monthly service amount for ongoing reporting after that initial period has expired.

Trxade also recently announced the appointment of former AshHealth healthcare market advisory firm President Ashton Maaraba as president of Trxade Group’s Bonum Health telemedicine practice.

Maaraba has over 20 years of experience in developing and directing strategic national sales, marketing and operating initiatives in ever-changing, dynamic environments, according to the company, and will work to help build long-term shareholder value by welcoming a growing number of patients under the Bonum Health Hub platform.

“Ashton is an intuitive leader with acute business acumen and expertise in channel development and market development,” Trxade Group CEO Suren Ajjarapu stated in describing the company’s forward strategy (http://ibn.fm/8hFn9). “I am confident in his ability to drive widespread adoption of Bonum Health amongst both employers seeking to provide unique healthcare perks to their workers as well as to individuals seeking a low-cost, convenient way to speak with a doctor.”

For more information, visit the company’s website at www.TrxadeGroup.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

QualityStocksNewsBreaks – The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (OTCQX: TGODF) to Hold AGM in December 2020

The Green Organic Dutchman Holdings (TSX: TGOD) (OTCQX: TGODF), a leading producer of premium, certified-organic cannabis, today announced plans for its Annual General Meeting (“AGM”). According to the update, due to ongoing concerns related to the 2019 novel coronavirus (“COVID-19”) and in order to provide its shareholders with the opportunity to have an in-person meeting, the Company has decided to hold its AGM on December 15, 2020. “Holding our AGM in December increases the likelihood of being able to have an in-person format, which is preferred, while we will continue to provide regular business updates reflecting our scaled operations to our shareholders through our quarterly disclosures,” Brian Athaide, CEO of TGOD, stated in the news release.

To view the full press release, visit http://ibn.fm/HfIWd

About The Green Organic Dutchman Holdings Ltd.
The Green Organic Dutchman Holdings Ltd. (TSX: TGOD) (US–OTC: TGODF) is a premium certified organic cannabis company focused on the health and wellness market. Its certified–organic cannabis is grown in living soil, as nature intended. The Company is committed to cultivating a better tomorrow by producing its products responsibly, with less waste and impact on the environment. Its two Canadian facilities have been built to LEED certification standards and its products are sold in recyclable packaging. In Canada, TGOD sells dried flower and oil, and recently launched a series of next–generation cannabis products such as organic teas, dissolvables and vapes. Through its European subsidiary, HemPoland, the Company also distributes premium hemp CBD oil and CBD-infused topicals in Europe. By leveraging science and technology, TGOD harnesses the power of nature from seed to sale.

TGOD’s Common Shares and warrants issued under the indentures dated November 1, 2017 and December 19, 2019 trade on the TSX under the symbol “TGOD”, “TGOD.WT” and “TGOD.WS”, respectively, and TGODF trades in the U.S. on the OTCQX. For more information on The Green Organic Dutchman Holdings Ltd., please visit www.TGOD.ca.

NOTE TO INVESTORS: The latest news and updates relating to TGODF are available in the company’s newsroom at http://ibn.fm/TGODF

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Enters Supply and Clinic Services Agreements with Medical Cannabis by Shoppers(TM)

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) and its subsidiaries have entered into both a product supply agreement and a clinic services agreement with Medical Cannabis by Shoppers(TM). Under the supply agreement, VIVO’s licensed producers will offer a broad portfolio of Canna Farms(TM) and Beacon Medical(TM) branded medical cannabis products through the Medical Cannabis by Shoppers(TM) online sales platform, accessible to patients across Canada. “We have a six-year track record of cultivating and producing high-quality, medical-grade cannabis and are thrilled to partner with Shoppers Drug Mart Inc.” Barry Fishman, CEO of VIVO, said in the news release. “VIVO is extremely committed to the medical cannabis market. We are pleased to be able to leverage the insights learned from over 100,000 patient visits to our Harvest Medicine clinics and telemedicine platform. As we continue to invest in product development to expand our medical cannabis product line and satisfy unmet patient needs, we are excited by the prospect of introducing our novel future offerings to Medical Cannabis by Shoppers™ patients.”

To view the full press release, visit http://ibn.fm/mxyQd

About VIVO Cannabis(TM)
VIVO Cannabis(TM) is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms(TM), Beacon Medical(TM), Fireside(TM), Fireside-X(TM), Lumina(TM) and Canadian Bud Collection(TM). The Company is expanding its production capabilities and distribution network. Harvest Medicine, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. The Company has a healthy balance sheet and is well-positioned to accelerate its path to profitability. For more information, visit www.VIVOCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Announces Results from 2020 Annual and Special Meeting

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP), a global innovator in drug delivery platforms, today announced the results of the 2020 Annual and Special Meeting (the “Meeting”). According to the update, the Meeting was held at 1:00 p.m. (Pacific Time) on June 23, 2020, whereby there were 47,819,789 shares of the Company represented in person or by proxy, constituting 53.38% of the Company’s issued share capital as at May 13, 2020, being the record date of the Meeting. All of the proposals are described in detail in the Company’s proxy statement filed with the Securities Exchange Commission via Edgar and with the BC Securities Commission and Ontario Securities Commission via SEDAR on May 25, 2020.

To view the full press release, visit http://ibn.fm/YPpAR

About Lexaria
Lexaria Bioscience Corp. is a global innovator in drug delivery platforms. Its patented DehydraTECH(TM) drug delivery technology changes the way Active Pharmaceutical Ingredients enter the bloodstream, promoting healthier ingestion methods, lower overall dosing and higher effectiveness for lipophilic active molecules. DehydraTECH increases bio-absorption; reduces time of onset; and masks unwanted tastes for orally administered bioactive molecules including cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (“NSAIDs”), nicotine and other molecules. Lexaria has licensed DehydraTECH to multiple companies in the cannabis industry for use in cannabinoid beverages, edibles and oral products; and to a world-leading tobacco producer for the development of smokeless, oral-based nicotine products. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 16 patents granted and over 60 patents pending worldwide. For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LXRP are available in the company’s newsroom at http://ibn.fm/LXRP

QualityStocksNewsBreaks – Marijuana Company of America, Inc. (MCOA) Enters Agreement with LA-Based White Lion for $10M Equity Line

Marijuana Company of America (OTCQB: MCOA), an innovative hemp and cannabis corporation, today announced its entry into an agreement with White Lion Capital, LLC (“White Lion”) for a $10,000,000 (ten million U.S. dollars) equity line of credit. White Lion, based out of Los Angeles, is a millennial run equity fund that makes investments into growing public companies. “We are very excited to acquire this new equity credit line as this will facilitate our efforts to execute our marketing strategies and Company projects. We have been working diligently to get all the pieces in place so that our roll-out will be smooth and unified,” MCOA Chief Marketing Officer Gloria Albarran Lynch said in the news release. “Our new product lines are positioned to engage a vast audience, both domestically and internationally. With the strength of the CBD wellness and beauty industry that is expected to grow beyond $25 billion globally in the next decade, we intend to take full advantage of this tremendous opportunity and take a leading position in this market.”

To view the full press release, visit http://ibn.fm/Kp9En

About Marijuana Company of America Inc.
MCOA is a corporation that participates in: (1) product research and development of legal hemp-based consumer products under the brand name hempSMART(TM), which targets general health and well-being; (2) an affiliate marketing and retail sales program to promote and sell its legal hemp-based consumer products containing CBD; (3) joint ventures and acquisitions of business entities engaged in the growth and sale of hemp and cannabis products in jurisdictions where cultivation is legal; and (4) the expansion of its business into ancillary areas as market opportunities in this segment mature and develop. For more information, visit www.MarijuanaCompanyofAmerica.com.

NOTE TO INVESTORS: The latest news and updates relating to MCOA are available in the company’s newsroom at http://ibn.fm/MCOA

QualityStocksNewsBreaks – Wrap Technologies, Inc.’s (NASDAQ: WRTC) BolaWrap at Forefront of Conversations as Agencies Reevaluate Use of Force Methods, Tools

Wrap Technologies (NASDAQ: WRTC), an innovator of modern policing solutions, today announced its receipt of more than 100 requests for BolaWrap demonstrations and training in the last month. According to the update, an additional 36 agencies have applied for grant assistance since the June 4 debut of the Grant Assistance Program. “Agencies have been reevaluating their use of force methods and tools during encounters with subjects who need to be detained,” Wrap Technologies Chief Operating Officer Mike Rothans said in the news release. “BolaWrap is at the forefront of conversations, as our remote restraint device is the only tool on an officer’s belt designed to restrain a noncompliant subject without inflicting pain.”

To view the full press release, visit http://ibn.fm/4Eaf2

About Wrap Technologies (NASDAQ: WRTC)
Wrap Technologies is an innovator of modern policing solutions. The Company’s BolaWrap 100 product is a patented, hand-held remote restraint device that discharges an eight-foot bola style Kevlar(R) tether to restrain an individual at a range of 10-25 feet. Developed by award winning inventor Elwood Norris, the Company’s Chief Technology Officer, the small but powerful BolaWrap 100 assists law enforcement to safely and effectively control encounters, especially those involving an individual experiencing a mental crisis. For information on the Company please visit www.WrapTechnologies.com. Examples of recent media coverage are available as links under the “Media” tab of the website.

NOTE TO INVESTORS: The latest news and updates relating to WRTC are available in the company’s newsroom at http://ibn.fm/WRTC

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Selected for Inclusion on the Russell Microcap Index

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, today announced that it has been selected to be added to the Russell Microcap Index at the conclusion of the 2020 Russell indexes annual reconstitution. According to a preliminary list of additions posted June 5, 2020, Trxade Group’s membership will be effective after the U.S. market opens on June 29, 2020. Russell Microcap Index membership, which remains in place for one year, ensures automatic inclusion in the appropriate growth and value style indexes. “We are pleased to be added to the Russell Microcap Index, raising Trxade Group’s visibility and public awareness within the investment community,” Suren Ajjarapu, chairman and CEO of Trxade Group, stated in the news release. “This marks an exciting capital markets milestone in the growth and trajectory of our Company as we continue to execute upon our growth strategy and raise awareness about the Company throughout the investment community.”

To view the full press release, visit http://ibn.fm/mI5Tj

About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; (1) the Trxade B2B trading platform with 11,400 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division, (3) the Bonum Health platform offering affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent pharmacies or mail order delivery. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

InsuraGuest Technologies (ISGI) Adds a New Product to its Insurtech Platform

-InsuraGuest Technologies is an insurtech company disrupting the insurance landscape by utilizing its proprietary software platform to deliver digital insurance to multiple sectors
-InsuraGuest’s new Business Liability product, administered through the company’s website InsureThePeople.com, will deliver coverage for more than 130 business class codes, including business property, business income, and general liability
-The insurtech industry is expected to see a CAGR of 10.8 percent between 2019 and 2025, according to ResearchAndMarkets.com analysts, delivering global revenues of $10.14 billion by 2025

The fast pace of technological change continues to drive changes in the way we work, and today, small businesses now account for 99% of American companies. Small business continues to evolve at a rate unseen by past generations – driven not only by emerging technologies but also by disruptive conditions such as the COVID-19 pandemic. Add in the nation’s 64.8 million freelancers, and there’s massive potential among small business owners and entrepreneurs who have evolving needs and are currently underserved in the business insurance space. InsuraGuest Technologies (TSX.V: ISGI), an insurtech company, is responding to that need in a way that’s revolutionizing insurance for small businesses.

Affordable insurance coverage remains a core need for the business community, and the insurtech industry provides a nimble response to the changing conditions companies are dealing with amid this evolutionary trend. Insurtech software company InsuraGuest Technologies, Inc. (TSX.V: ISGI) already established itself as a Hospitality Liability Policy solution for the hotel and vacation rental industry, but recently began to upscale its offerings for a much broader clientele.

“We are taking digital insurance and reimagining it, reinventing it, and revolutionizing it by harnessing the power of our insurtech platform to deliver that digital insurance to multiple sectors,” InsuraGuest Chairman and CEO Douglas Anderson stated in a recent news release (http://ibn.fm/oX8a1) about the company’s new Business Owner Policy (“BOP”) insurtech portal, www.InsureThePeople.com. “Additionally, by advancing our product offerings, we are creating multiple avenues of revenue, which will result in greater shareholder value.”

Through its wholly-owned U.S. subsidiary, Insure The People, LLC,(www.InsureThePeople.com), InsuraGuest will digitally deliver BOP policies to cover more than 130 class codes, including business property coverage, business income, enhanced equipment breakdown (such as micro-circuity), general liability and employment practices liability at the outset.

Once the portal launches, InsureThePeople (“ITP”) expects to add coverage for sectors such as Blanket Additional Insured, employee benefits liability, hired and non-owned auto, liquor liability, miscellaneous professional liability, scheduled property floater, cyber risk, workers’ comp, errors and omissions, and directors’ and officers’ coverages.

InsuraGuest Insurance Agency will operate InsureThePeople.com policies in all 50 states and the District of Columbia, where InsuraGuest Insurance Agency is licensed to sell insurance. The company also just celebrated the news that it can finish streamlining how it issues policies for its hospitality coverage, thanks to a certificate of compliance issued to the company’s wholly-owned U.S. subsidiary InsuraGuest Risk Purchasing Group, LLC (“RPG”) by the Insurance Department for the state of Utah, where InsuraGuest’s headquarters are located.

The insurtech industry is expected to continue its upward trajectory as an increasing number of businesses evaluate their strategies to keep up with the evolving marketplace worldwide. A recent report by analysts at ResearchAndMarkets.com projected that global market revenue for the industry will reach $10.14 billion by 2025, growing at a CAGR of 10.80 percent during the six years leading up to that point (http://ibn.fm/n64CU). Expect InsuraGuest Technologies to be leading the way.

For more information, visit the company’s website at www.InsuraGuest.com.

NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

QualityStocksNewsBreaks – National Storm Recovery (NSRI) CEO Discusses Exceptional Q1 Financial Results, Opportunities in Exclusive Interview

National Storm Recovery Inc. (OTC: NSRI) today announced that its CEO, Tony Raynor, was featured in an exclusive audio interview with NetworkNewsWire (“NNW”), a financial news and content distribution company and one of 45+ brands in the InvestorBrandNetwork (“IBN”). During the interview, Raynor discussed National Storm Recovery’s exceptional financial results for the quarter ended March 31, 2020, and also examined potential opportunities for growth as the Atlantic hurricane season continues to ramp up. “We study these weather trends. In April, they set records across the world according to the National Oceanic and Atmospheric Administration (NOAA), and 2020 is set to be the warmest year on record,” Raynor said, discussing the possibility of particularly fruitful months to come for National Storm Recovery, as analysts continue to forecast a record-breaking 2020 hurricane season. “We definitely have a lot of preparation and planning that’s in place to jump right into the action and help people get their cities back in order again, not only taking the tree debris but also reprocessing it to make it into usable products again.”

To view the full press release, visit http://ibn.fm/NZ3ol

About National Storm Recovery, Inc. (NSRI)
National Storm Recovery Inc., based in Florida, through its subsidiaries, provides tree services, debris hauling and removal, biomass recycling, mulch manufacturing, packaging and sales. The company was established with the objective of providing a solution for the treatment and handling of tree debris that has historically been disposed of in landfills, creating an environmental burden and pressure on disposal sites around the nation. The company and its Sustainable Green Team’s solutions are founded in sustainability, based on vertically integrated operations that begin with collecting of tree debris through its tree services division, and collection sites, then through its processing division, recycling and using that tree debris as a feedstock that is manufactured into a variety of organic, attractive, next-generation mulch products that are packaged and sold to landscapers, installers and garden centers. The company plans to expand its operations through a combination of organic growth and strategic acquisitions that are both accretive to earnings and positioned for rapid growth from the resulting synergistic opportunities identified. The company’s customers include governmental, residential and commercial customers and, now, big box retailers. To learn more about National Storm Recovery, visit www.NationalArborCare.com

NOTE TO INVESTORS: The latest news and updates relating to NSRI are available in the company’s newsroom at http://ibn.fm/NSRI

QualityStocksNewsBreaks – Sugarmade, Inc. (SGMD) Announces Plans to Expand into Cannabis Cultivation in Verticalization of BudCars Model

Sugarmade (OTCQB: SGMD), together with its BudCars Cannabis Delivery Service (“BudCars”), today announced that the Company is submitting an application to the California Bureau of Cannabis Control to expand into cannabis cultivation as part of a strategic plan to partially verticalize its BudCars model, a process that management strongly believes will further increase the Company’s gross profitability over the long-term and provide a rapid potential path to branded product development. According to the update, the Company has already secured a property containing a 5,000 square-foot indoor premium cannabis cultivation facility located in very close proximity to its Sacramento BudCars hub. “BudCars is a high margin, high-growth business. But it will still benefit from verticalization,” Sugarmade CEO Jimmy Chan said in the news release. “Because we have access to our end-market consumer directly and we have cultivation expertise and a premium grow facility, an expansion into cultivation to connect the dots is a clearly advantageous move. In addition, because BudCars is a rapidly growing distribution channel, we will have a clear edge in the marketplace in terms of the capacity to establish our own branded cannabis product line.”

To view the full press release, visit http://ibn.fm/HtkdQ

About Sugarmade, Inc.
Sugarmade, Inc. (OTCQB: SGMD) is a product and branding marketing company investing in operations and technologies with disruptive potential. Its Brand portfolio includes CarryOutsupplies.com, SugarRush(TM) and Budcars.com. For more information, please reference www.Sugarmade.com.

NOTE TO INVESTORS: The latest news and updates relating to SGMD are available in the company’s newsroom at http://ibn.fm/SUGAR

Energy Fuels Inc.’s (NYSE American: UUUU) (TSX: EFR) Plans to Redeem Half of Outstanding Debt Early

-UUUU will pay off half of its debt in July, plans to be debt free by the end of 2020
-Expects to save about $350,000 in avoided interest
-Energy Fuels has focused on strategy to eliminate debt over the past several years with minimal impact to shareholders

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the largest uranium mining company in the United States, plans to take a significant step forward in its strategy to reduce debt and further strengthen its balance sheet by redeeming half of its outstanding debt earlier than planned (http://ibn.fm/eAj5w). The company notified holders of the outstanding floating rate convertible unsecured subordinated debentures of its plans earlier this month.

“Energy Fuels is proud to announce that we are paying off half of our debt on July 14, 2020, and that we expect to become debt-free by the end of 2020,” said Energy Fuels president and CEO Mark S. Chalmers. “We are proactively managing our remaining debt to ensure we have the ability to pay it off on our own timing and terms and with minimal disruption. We believe it makes sense to redeem half of the Debentures now because the U.S.-Canada exchange rate is favorable, we have sufficient cash available, and we will avoid approximately US$350,000 in interest payments in 2020 by doing so. We will address the remaining Cdn$10,430,000 balance over the next several months when we think the timing is most appropriate.”

On July 14, 2020, UUUU will redeem the principal amount of Cdn$10,430,000, half of the outstanding Cdn$20,860,000 debentures, originally due Dec. 31, 2020. The debentures are redeemable for an amount equal to 101% of the principal due, plus accrued and unpaid interest thereon, up to but excluding the redemption date.

The plan calls for the debentures to be redeemed on a pro rata basis to the nearest multiple of Cdn$1,000 in accordance with the principal amount of the debentures registered in the name of each holder, or in such other manner as deemed equitable, subject to any applicable regulatory approvals. The record date for determining the holders of the debentures to be redeemed is slated for July 8, 2020. Following the partial redemption, Cdn$10,430,000 aggregate principal amount of the debentures will remain outstanding and shall continue to be subject to the terms of the indenture and remain listed on the Toronto Stock Exchange.

“Many junior uranium producers and developers in North America are currently incurring significant amounts of debt to fund exploration and development activities and to cover corporate overheads,” Chalmers said. “However, without sufficient cash flow, servicing this debt can become extremely burdensome and destructive to shareholder value. Instead, Energy Fuels has focused on a strategy to reduce our debt load over the past several years, including paying off our debt to the State of Wyoming in 2018, all with minimal impact to our shareholders. Furthermore, we do not expect to incur more debt in the future without a clear, short-term path toward positive cash flow. We will continue to manage all aspects of our business proactively, including maintaining our position as the leading U.S. uranium producer, advancing our exciting rare earth initiatives, and maintaining the other significant aspects of our business plan, including our significant inventories of uranium and vanadium.”

Based in Lakewood, Colorado, Energy Fuels holds three of America’s key uranium production centers: the Nichols Ranch (“ISR”) project in Wyoming, the Alta Mesa ISR Project in Texas, and the White Mesa Mill in Utah — the only conventional uranium mill operating in the U.S. today with a licensed capacity of more than 8 million pounds of U3O8 per year. With an asset portfolio that boasts more uranium production facilities, in-ground resources, and production capacity than any other producer, Energy Fuels is in a unique position to take charge as the leading producer of uranium in an era of viable transformation of the U.S. nuclear industry. Energy Fuels is also making significant progress in entering the U.S. rare earth processing business.

For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

QualityStocksNewsBreaks – Willow Biosciences Inc. (TSX: WLLW) (OTCQB: CANSF) Appoints New SVP to Lead Sales and Marketing of New Line of Cannabinoids

Willow Biosciences (TSX: WLLW) (OTCQB: CANSF) on Monday announced that Christopher Speed has joined the Company as Senior Vice President, Sales and Marketing, effective July 1, 2020. In this role, Speed will be responsible for leading the sales and marketing of Willow’s new line of cannabinoids, along with the Company’s strategic planning and customer initiatives. “We are very excited to have Chris join our team,” Trevor Peters, president and CEO of Willow, stated in the news release. “His expertise and experience in sales and marketing along with his strong background in the ingredients space with consumer packaged goods will be an invaluable asset as we transition Willow into a customer-focused Company.”

To view the full press release, visit http://ibn.fm/LpK9o

About Willow Biosciences Inc.
Willow is a Canadian biotechnology company based in Calgary, Alberta, that produces high purity, plant-derived compounds that provide building blocks for the global pharmaceutical, health and wellness, and consumer packaged goods industries. Willow’s current focus is in the production of cannabinoids for the treatment for pain, anxiety, obesity, brain disorders, among other significant indications. Willow’s science team has a proven track record of developing manufacturing technologies for high purity compounds in pain and cancer treatments. Willow’s manufacturing process creates a consistent, scalable and sustainable product that allows for the discovery and development of new life changing drugs. For more information, visit the company’s website at www.WillowBio.com.

NOTE TO INVESTORS: The latest news and updates relating to WLLW are available in the company’s newsroom at http://ibn.fm/WLLW

QualityStocksNewsBreaks – Canopy Rivers Inc.’s (TSX: RIV) (OTC: CNPOF) Most Recent Addition to Portfolio of Disruptive Cannabis Companies Receives Health Canada License

Canopy Rivers (TSX: RIV) (OTC: CNPOF) on Monday announced that the most recent addition to its portfolio of disruptive cannabis companies, Dynaleo Inc., has received its Standard Processing License from Health Canada. According to the update, this follows the completion and commissioning of Dynaleo’s 27,000 square foot purpose-built facility and is a key milestone as it aims to ramp up production of white label gummies for the Canadian recreational market. “We are thrilled with the momentum at Dynaleo,” Narbé Alexandrian, president and CEO of Canopy Rivers, stated in the news release. “Data shows that the total addressable market for edibles, and specifically gummies, remains large. Licensed producers haven’t yet been able to scale their production to meet consumer demand for this product category, and brand loyalty has not yet been achieved the same way we have seen in mature U.S. markets for similar products. We believe that Dynaleo will be a key partner in manufacturing gummies brands that will be leaders in the 2.0 market.”

To view the full press release, visit http://ibn.fm/w8flW

About Canopy Rivers
Canopy Rivers is a venture capital firm specializing in cannabis with a portfolio of 18 companies across various segments of the cannabis value chain. Canopy Rivers believes that bringing together people, capital and ideas raises the potential of the entire cannabis industry. By leveraging its industry insights, in-house expertise, and thesis-driven approach to investing, Canopy Rivers aims to provide shareholders with exposure to specialized and disruptive cannabis companies. The company’s mission is to invest in innovators across the cannabis value chain, help them grow, and ultimately create value by guiding these companies towards a monetization event. Together with its portfolio, Canopy Rivers is helping build the cannabis industry of tomorrow, today. For more information, visit www.CanopyRivers.com.

NOTE TO INVESTORS: The latest news and updates relating to CNPOF are available in the company’s newsroom at http://ibn.fm/CNPOF

QualityStocksNewsBreaks – Trxade Group, Inc. (NASDAQ: MEDS) Building Parallel Network to Healthcare Chains Such as Walgreens or CVS

Trxade Group (NASDAQ: MEDS), an integrated drug procurement, delivery and healthcare platform, is building a parallel network to healthcare chains such as Walgreens or CVS by bringing together independent pharmacies across the country under its technology and by offering a promise of same-day delivery. The company, which was recently uplisted to Nasdaq, has been bringing together independent pharmacies under one umbrella through its web-based purchasing platform and is now present in all 50 states and rapidly adding 100-150 pharmacies every month. In an interview with AlphaStreet, Trxade CEO Suren Ajjarapu said the company’s focus is to empower independent pharmacies to compete with bigger healthcare retailers such as CVS Health (NYSE: CVS) or Walgreens Boots Alliance (NASDAQ: WBA) by helping them achieve same-day delivery of drugs. “If you look at the telemedicine portals, those scripts are walking into the Walgreens and CVS,” Suren said in the interview. “We want to see whether we can take these scripts to the independents. By giving them business, they will buy more from us. So that’s the strategy.”

To view the full article release, visit http://ibn.fm/hDJV9

About Trxade Group, Inc.
Headquartered in Tampa, Florida, Trxade Group, Inc. (NASDAQ: MEDS) is an integrated drug procurement, delivery and healthcare platform that fosters price transparency, thereby improving profit margins for both buyers and sellers of pharmaceuticals. Trxade Group operates across all 50 states with the central mission of making healthcare services affordable and accessible. Founded in 2010, Trxade Group is comprised of four synergistic operating platforms; (1) the Trxade B2B trading platform with 11,400 registered pharmacies, (2) Integra Pharma Solutions, Trxade Group’s virtual wholesale division, (3) the Bonum Health platform offering affordable telehealth services; and (4) the DelivMeds app, which coordinates a nationwide distribution network through independent pharmacies or mail order delivery. For additional information, please visit www.Trxade.com, www.DelivMeds.com and www.BonumHealth.com.

NOTE TO INVESTORS: The latest news and updates relating to MEDS are available in the company’s newsroom at http://ibn.fm/MEDS

Is InsuraGuest Technologies Inc. (TSX.V: ISGI) the Next Insurtech Unicorn?

-InsuraGuest partners with hospitality expert Adam Gatto to increase hospitality footprint
-InsuraGuest’s Hospitality Liability policy ideal for vacation-rental operators
-Mammoth market: vacation rental companies number 23,000 in U.S.; 115,000 globally

In the hospitality business, it’s not who you know but who knows you, which is why the partnership between InsuraGuest Technologies (TSX.V: ISGI) and hospitality and hotel expert Adam Gatto is a big deal. Gatto heads AAG Capital Management (“AAG”), which has been involved with single-asset and portfolio sales of select-service hotels, large convention hotels, and hotel development. Joining forces with Gatto should expand InsuraGuest’s presence in new markets (http://ibn.fm/TIF1h).

InsuraGuest is a pioneer in the fast-developing insurtech sector of digitized insurance products that reduce operating costs and increase customer satisfaction. The company has already launched a hospitality policy that offers hotel owners and vacation-rental operators a way to increase property revenue and decrease risk and claims profiles while protecting their guests. Now, ISGI is turning attention to other niches in the mammoth insurance marketplace; this impressive start-up could be the next Unicorn in the insurtech space.

In the same way fintech disrupted financial services, insurtech is revolutionizing the staid insurance industry. It’s an industry badly in need of disruption, with many of its practices and products outdated and change slow in coming. For example, some maritime contracts such as bottomry and respondentia date back to ancient Babylon, circa 2000 BCE, and yet were still quite common in the nineteenth century. The development of digital technologies has made the industry’s timeworn operations seem even more antiquated. But these technologies also provide ways to make insurance protection more accessible, affordable, and better tailored to individual needs.

Many corners of the insurance industry are ripe for reinvention. Some are already in upheaval, with upstart digitech insurance providers laying claim to niche after niche, sometimes with amazing results. One such provider, Lemonade, founded just five years ago, is now worth $2 billion – according to Forbes (http://ibn.fm/w2JwX) – after the company raised $300 million. The company uses behavioral economics, artificial intelligence, and chatbots to deliver renter’s and homeowner’s insurance policies at greatly reduced prices.

Another provider — Root Insurance — also targets homeowners. Root first ventured into the car insurance marketplace with a novel product that bases the policy premium on the motorist’s driving behavior. After its latest funding round in September 2019, the company was valued at $3.65 billion (http://ibn.fm/7Lyog). And Next Insurance, which offers general liability coverage to small business, is now the nation’s latest insurtech Unicorn, according to PitchBook, crossing $1 billion in valuation after reinsurance giant, Munich Re, ploughed $250 million into the start-up (http://ibn.fm/75A5j).

Munich Re’s investment in Next Insurance is not surprising. A major driver of demand for digitization has come from traditional carriers as they move to simplify transaction processes and improve customer service. These establishment insurers and brokers are turning to insurtech start-ups to help update their legacy systems and increase market responsiveness, reports a recent Boston Consulting Group (“BCG”) study. The reasons are obvious. Digitization is expected to significantly improve the insurance industry’s core business of risk measurement and management, which in turn should allow more consumers to enjoy basic insurance protections at less cost than is currently available.

InsuraGuest’s Hospitality product called Hospitality Liability offers coverages that protect hotels and vacation-rental properties, addressing covered claims from guests during their stays. The vacation-rental market looks particularly promising. In recent times, it has expanded by around 6.9%, a growth rate that tops regular hotel bookings. Market revenues are estimated to have reached $57.7 billion at the end of 2019, driven by the prodigious 115,000 vacation-rental companies operating globally, 23,000 of which are based in the United States. Undoubtedly, many of these companies will see InsuraGuest’s Hospitality Liability coverage as a way to add value to their offerings.

As insurtech continues to grow and disrupt the insurance industry, InsuraGuest Technologies has stepped into the insurtech/fintech space offering a tremendous amount of value with powerful new digital insurance products. That begs the question: could InsuraGuest Technologies be the next Unicorn to watch out for?

For more information, visit the company’s website at www.InsuraGuest.com.

NOTE TO INVESTORS: The latest news and updates relating to ISGI are available in the company’s newsroom at http://ibn.fm/ISGI

SRAX Inc. (NASDAQ: SRAX) Launches App for New Investor Intelligence Platform Sequire

-App will allow company executives to monitor shareholders’ trading behavior from any location
-Platform enables diverse account management capabilities, including ability to build contact profiles on shareholders, track outstanding warrants and shares, manage social media & news campaigns remotely
-Online modes of connecting with investors have become especially relevant in wake of COVID-19 pandemic

SRAX (NASDAQ: SRAX), a digital marketing pioneer focused on providing consumer data management services, has recently launched a new app for its investor intelligence platform, Sequire. Sequire, which enables companies to monitor their shareholders’ buying and selling behavior and interact with them through a number of digital mediums, has seen a rapid gain in adherents following the onset of the COVID-19 pandemic, which has caused demand for virtual investor relations platforms and services to skyrocket. Now through the launch of its proprietary mobile application, Sequire will allow CEOs & CFOs of public companies to monitor their investors’ trading behaviors anywhere they go.

The application, which is available to download for free on the App Store and Google Play, includes many of the features which have been popularized through the Company’s existing service. Subscribers will now be able to gain insights on their shareholder’s trading activity, analyze market-maker activity within their listed equities through the use of level 2 trading data and even turn real-time conference visitor data into targeted cross-channel ads. The app will also provide users with a business card scanner, enabling executives to quickly scan business cards to save and organize contact information from people they meet.

“We are thrilled to launch the Sequire mobile app enabling our clients to now monitor their investors’ behaviors and their contributions anytime and anywhere,” says SRAX CEO and founder Christopher Miglino (http://ibn.fm/p5v1M). “We’ll also be launching more exciting mobile features in the next few months, so stay tuned.”

Investor relations functions have increasingly gone digital as companies find themselves unable to meet with their investors in person. Hundreds of investor conferences across the world have been moved to virtual platforms while webinars have gained in popularity—the latter medium allowing presenters to target and reach far wider audiences than ever before. However the shift to digital mediums has been juxtaposed against record trading volumes and market volatility, with monthly equity transactions hitting historic highs across a multitude of global stock exchanges in the first quarter (http://ibn.fm/iUh0A). As investors have sought to gain greater clarity on corporate prospects during these uncertain times, virtual IR platforms such as SRAX Inc’s Sequire have found themselves in greater demand than ever before.

For more information, visit the company’s website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

QualityStocksNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Announces Regulatory Review

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human optimization sciences company with an emphasis on ketamine and psychedelic medicine, today announced that it has been selected for a continuous disclosure review by the British Columbia Securities Commission (the “Commission”). The review relates to Champignon’s disclosure obligations since it became a reporting issuer on February 6, 2020 and includes a review of the disclosure surrounding certain recent acquisitions completed by the Company. “With the recent growth and interest in our industry, ensuring our disclosure obligations are satisfied is at the forefront of our attention. Ensuring fulsome and timely disclosure is vital to the success of our Company, and development of our industry with the investing public,” Champignon CEO Dr. Roger McIntyre stated in the news release. “We look forward to working with staff of the British Columbia Securities Commission to complete their review, and are hopeful that trading will resume as soon as possible.”

To view the full press release, visit http://ibn.fm/8EhJL

About Champignon Brands Inc.
Champignon Brands (CSE: SHRM) is focused on the formulation and manufacturing of novel ketamine, anaesthetics and adaptogenic delivery platforms for the nutraceutical and psychedelic medicine while being supported by a leading psychedelics medicines clinic platform. The Company is pursuing the development and commercialization of rapid onset treatments capable of improving health outcomes, such as depression and post-traumatic stress disorder (“PTSD”), as well as substance and alcohol use disorders. Under a collaborative research agreement with the University of Miami’s Miller School of Medicine, the Company is conducting preclinical studies and eventual human clinical trials, with the objective of demonstrating safety and efficacy of the combination of psilocybin and cannabidiol in treating mTBI with PTSD or stand-alone PTSD. Champignon continues to be inspired by sustainability, as its medicinal mushroom-infused SKUs are organic, non-GMO and vegan certified. For more information, visit the Company’s website at www.ChampignonBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to SHRM are available in the company’s newsroom at http://ibn.fm/SHRM

QualityStocksNewsBreaks – Hemptown Organics Corp to Participate in Prohibition Partners LIVE Virtual Conference

Hemptown Organics on Friday announced its participation in the Prohibition Partners LIVE virtual conference occurring June 22 and 23. The event brings together delegates from every corner of the globe to help share knowledge, gain insight and shape the future of cannabis. The virtual conference replicates a traditional event in an online environment, providing attendees across the globe access to a live stream of talks and networking opportunities with industry experts regardless of location. Hemptown will participate in the conference as part of the ProCapital presentation series partnership with MAZAKALI. “We look forward to presenting the progress Hemptown has made over the past year in front of a global audience, at a great forum put together by Prohibition Partners and MAZAKALI,” Hemptown CEO Eric Gripentrog said in the news release. “During these unprecedented times, connecting with the market is as important as ever, and being able to connect with investors and market partners through an innovative platform is something we are very excited to be a part of.”

To view the full press release, visit http://ibn.fm/OPJZf

About Hemptown Organics Corp.
Hemptown is growing some of the finest hemp in the world to meet the global demand for cannabinoid-based products. State-of-the-art cultivation, product manufacturing capability and a strong leadership team are the pillars for Hemptown’s growth model as the Company pushes into the consumer packaged goods sectors with top quality white label and branded product lines for the consumer market. Hemptown’s fully operational (FDA-licensed and cGMP certified) nutraceutical manufacturing facility in Oregon gives the Company a strong leadership position in a global market that continues to grow exponentially. For more information, visit www.HemptownUSA.com.

QualityStocksNewsBreaks – Foresight Autonomous Holdings Ltd. (NASDAQ: FRSX) (TASE: FRSX) Regains Compliance with Nasdaq Listing Rule 5550(a)(2)

Foresight Autonomous Holdings (NASDAQ: FRSX) (TASE: FRSX), an innovator in automotive vision systems, today announced its receipt of notification from the Listing Qualifications Department of The Nasdaq Stock Market (“Nasdaq”) that it has regained compliance with Nasdaq Listing Rule 5550(a)(2), concerning minimum bid price listing requirements. As previously announced, Nasdaq had notified Foresight that its American Depositary Shares (“ADSs”) failed to maintain a minimum bid price of $1.00 over 30 consecutive business days as required by the Listing Rules of The Nasdaq Stock Market. Nasdaq, on June 19, 2020, provided confirmation to the company that, for the last 10 consecutive business days, from June 5 to 18, 2020, the closing bid price of its ADSs has been at $1.00 per share or greater. Accordingly, Foresight has regained compliance with Listing Rule 5550(a)(2) and this matter is now closed.

To view the full press release, visit http://ibn.fm/gZg7D

About Foresight
Foresight Autonomous Holdings Ltd. (NASDAQ and TASE: FRSX), founded in 2015, is a technology company engaged in the design, development and commercialization of sensors systems for the automotive industry. Through the company’s wholly owned subsidiaries, Foresight Automotive Ltd. and Eye-Net Mobile Ltd., Foresight develops both “in-line-of sight” vision systems and “beyond-line-of-sight” cellular-based applications. Foresight’s vision sensor is a four-camera system based on 3D video analysis, advanced algorithms for image processing, and sensor fusion. Eye-Net Mobile’s cellular-based application is a V2X (vehicle-to-everything) accident prevention solution based on real-time spatial analysis of clients’ movement.

The company’s systems are designed to improve driving safety by enabling highly accurate and reliable threat detection while ensuring the lowest rates of false alerts. Foresight is targeting the semi-autonomous and autonomous vehicle markets and predicts that its systems will revolutionize automotive safety by providing an automotive-grade, cost effective platform and advanced technology.

For more information about Foresight and its wholly owned subsidiary, Foresight Automotive, visit www.ForesightAuto.com

NOTE TO INVESTORS: The latest news and updates relating to FRSX are available in the company’s newsroom at http://ibn.fm/FRSX

QualityStocksNewsBreaks – VIVO Cannabis Inc. (TSX: VIVO) (OTCQX: VVCIF) Announces Expansion of Cultivation and Processing Capacity

VIVO Cannabis (TSX: VIVO) (OTCQX: VVCIF) today announced that its wholly-owned subsidiary, Canna Farms Limited, has received all necessary Health Canada approvals to commence operations in its Phase 5 expansion, and that its wholly-owned subsidiary, ABcann Medicinals Inc. (“NCC”), has begun commercial production in its ethanol extraction suite. According to the update, the Phase 5 expansion of the Hope, British Columbia facility consists of 10,000 square feet of production space customized to incorporate Canna Farms’ two-tier growing systems, as well as vegetative, mother and processing rooms and storage vaults. “Health Canada’s approval of Phase 5 is a major milestone for the Canna Farms team because our two-tiered approach will allow us to grow twice as many plants in the same footprint as most conventional cultivators, allowing us to meet the growing demand for craft quality cannabis,” Dan Laflamme, president of Canna Farms, said in the news release. “In addition to our two-tiered production, Phase 5 is equipped with three processing rooms to provide space for our automated pre-rolled machine, expected to be commissioned this summer, and for expanded production of our solvent-less extracts including kief, bubble hash, and various forms of rosin.”

To view the full press release, visit http://ibn.fm/l1W47

About VIVO Cannabis(TM)
VIVO Cannabis(TM) is recognized for trusted, premium cannabis products and services. It holds production and sales licenses from Health Canada and operates world-class indoor and seasonal airhouse cultivation facilities with proprietary plant-growing technology in Hope, British Columbia and Napanee, Ontario. VIVO has a collection of premium brands, each targeting different customer segments, including Canna Farms(TM), Beacon Medical(TM), Fireside(TM), Fireside-X(TM), Lumina(TM) and Canadian Bud Collection(TM). The Company is expanding its production capabilities and distribution network. Harvest Medicine, VIVO’s patient-centric, scalable network of medical cannabis clinics, has serviced over 100,000 patient visits. VIVO is pursuing several partnership and product development opportunities and is focusing its international efforts on Germany and Australia. The Company has a healthy balance sheet and is well-positioned to accelerate its path to profitability. For more information, visit www.VIVOCannabis.com.

NOTE TO INVESTORS: The latest news and updates relating to VVCIF are available in the company’s newsroom at http://ibn.fm/VVCIF

QualityStocksNewsBreaks – SinglePoint, Inc.’s (SING) Direct Solar Lands Large Commercial Project

SinglePoint (OTCQB: SING) on Friday announced a new video during which its CEO Greg Lambrecht joins MoneyTV with Donald Baillargeon to discuss the latest commercial deal, covering an Illinois-based office complex and parking stalls, landed by the company’s subsidiary, Direct Solar America. According to the update, the company has executed the energy services development agreement with the client, as well as the co-development compensation agreement with Lux Power LLC. The client has agreed to and executed the solar power purchase agreement and is awaiting final approval from the financing source. The project’s estimated value is approximately $1.75M and covers the commercial solar system components for the office complex roof as well as the existing parking lot structure. This specific commercial project’s estimated value is roughly 50 times greater than the historical residential rooftop solar installation, which can average between $30K to $35K per installation.

To view the full press release, visit http://ibn.fm/YAGUI

About SinglePoint, Inc.
Founded in 2011, SinglePoint, Inc. invests in and acquires brands and companies that will benefit from injection of growth capital and its sales and marketing expertise. The company’s portfolio currently includes solar, hemp and technology applications. SinglePoint is working to grow the company to a multi-national brand. For more information, visit the company’s website at www.SinglePoint.com.

NOTE TO INVESTORS: The latest news and updates relating to SING are available in the company’s newsroom at http://ibn.fm/SING

QualityStocksNewsBreaks – Why Pure Extracts Corp. Is ‘One to Watch’

Headquartered in Pemberton, British Columbia, Pure Extracts is a private, plant-based extraction company with a new vertical in functional mushrooms. A recent article discussing the company reads, “Current research is finding psychedelic benefits including anti-tumor, anti-viral, detoxification, immune function and mental wellness. As such, psychedelic compounds are now being examined by leading medical research and academic institutions for treatment of depression, PTSD, anxiety, bipolar disorder, obesity, narcolepsy, OCD, Alzheimer’s, ADHD, and drug and alcohol dependence. In 2020, the FDA granted breakthrough therapy status to psychedelics for treatment-resistant depression, with approvals anticipated in 2021. . . . Pure Extracts is well positioned to partner with organizations planning to develop both functional and psychedelic products. A dealer’s license with Health Canada will enable buying, selling and producing of psychedelics in an EU-GMP-compliant environment. The company’s 10,000-square-foot facility is designed for EU-GMP certification, which allows for international sales.”

To view the full article, visit http://ibn.fm/Q6oXK

About Pure Extracts
Pure Extracts is positioned to enter the commercial cannabis sector as an experienced producer. Led by a team of qualified experts in the space and providing cutting-edge CO2 extraction technology, the company is set up for long-term strategic distribution and product innovation. For more information, visit the company’s website at www.PureExtractsCorp.com.
NOTE TO INVESTORS: The latest news and updates relating to Pure Extracts are available in the company’s newsroom at http://ibn.fm/Pure

QualityStocksNewsBreaks – Pressure BioSciences Inc. (PBIO) Pending Acquisition Target Secures $3.5M Initial Hand Sanitizer Order

Pressure BioSciences (OTCQB: PBIO), recently announced that SkinScience Labs (“SSL”) has secured an initial $3.5 million order for its premium FDA-registered dermatological hand sanitizer product (http://ibn.fm/KE7x5). A leader in the development and sale of broadly enabling, pressure-based instruments, consumables, and platform technology solutions, Pressure BioSciences will acquire SSL through its planned acquisition of Cannaworx, which is expected to close by June 30, 2020. A recent article discussing the company further reads, “The $3.5 million order announced on June 11 is merely the initial order for a four-month supply of the premium, dermatological, hand-sanitizer product. Mr. Morrison expects future orders and other substantial ongoing growth in the hand-sanitizer product area. ‘Since the May 14 announcement that we were entering the multibillion-dollar hand-sanitizer market, I have taken the opportunity to discuss our new, premium-grade, hand-sanitizer product with several large U.S. retail outlets. The reception we received was extremely positive,’ he said.”

To view the full article, visit http://ibn.fm/1v1S0

About Pressure BioSciences Inc.
Pressure BioSciences is a leader in the development and sale of innovative, broadly enabling, pressure-based solutions for the worldwide life sciences and other industries. Its products are based on the unique properties of both constant (i.e., static) and alternating (i.e., pressure cycling technology, or PCT) hydrostatic pressure. PCT is a patented, enabling technology platform that uses alternating cycles of hydrostatic pressure between ambient and ultra-high levels to safely and reproducibly control biomolecular interactions (e.g., cell lysis, biomolecule extraction). The company’s primary focus is in the development of PCT-based products for biomarker and target discovery, drug design and development, biotherapeutics characterization and quality control, soil and plant biology, forensics, and counter-bioterror applications. Additionally, major new market opportunities have emerged in the use of its pressure-based technologies in the following areas: (1) the use of its recently acquired, patented technology from BaroFold Inc. (the “BaroFold” technology) to allow entry into the biopharma contract services sector, and (2) the use of its recently patented, scalable, high-efficiency, pressure-based Ultra Shear Technology (“UST”) platform to (i) create stable nanoemulsions of otherwise immiscible fluids (e.g., oils and water) and to (ii) prepare higher quality, homogenized, extended shelf-life or room-temperature, stable, low-acid liquid foods that cannot be effectively preserved using existing nonthermal technologies. For more information, visit www.PressureBioSciences.com.

NOTE TO INVESTORS: The latest news and updates relating to PBIO are available in the company’s newsroom at http://ibn.fm/PBIO

QualityStocksNewsBreaks – Vivos Therapeutics Inc. Develops Potential, Nonsurgical Solution for Obstructive Sleep Apnea

Vivos Therapeutics, an emerging global leader in the treatment of obstructive sleep apnea (“OSA”), has developed a groundbreaking remedy that holds the potential to be a possible solution for the life-threatening condition. A recent article further discussing the company reads, “This innovative medical device technology company has created and patented a novel system to combat OSA caused by deficiencies and other tissue anomalies in craniofacial anatomy development — the root cause behind 98% of OSA cases. The Vivos System requires no surgery but is a multidisciplinary treatment protocol that consists of comfortable and customized oral devices. Over the typical 18-to-24-month course of treatment, we believe the patient’s upper airway is remodeled and enhanced, thereby reducing the tissue obstructions that gave rise to the OSA. Thus, Vivos technology represents the first true hope of an effective and lasting nonsurgical OSA solution that, in most cases, doesn’t require a lifetime of treatment intervention. For the first time, the salutation ‘good night’ will truly mean a good night for these sufferers.”

To view the full article, visit http://ibn.fm/nyKrh

About Vivos Therapeutics Inc.
Vivos Therapeutics is an emerging global leader in the treatment of obstructive sleep apnea (“OSA”), a debilitating condition affecting nearly 1 billion people worldwide. Headquartered in Denver, Colorado, the company utilizes proprietary, groundbreaking technology; a proven, go-to-market strategy; and a powerful executive team dedicated to changing the face of health care by helping people of all ages properly breathe and sleep. At the core of Vivos’ mission to eradicate OSA is the Vivos System(R), a revolutionary clinical breakthrough in the treatment of sleep apnea caused by craniofacial anatomy development. The Vivos System multidisciplinary treatment protocol involves collaboration between physicians, specially trained dentists who have completed advanced training in craniofacial sleep medicine, and other ancillary health-care providers. In support of its growth strategy, Vivos has established FDA-approved and registered manufacturing facilities in the United States, Canada and Asia. For more information, visit the company’s website at www.VivosLife.com.

NOTE TO INVESTORS: The latest news and updates relating to Vivos Therapeutics are available in the company’s newsroom at http://ibn.fm/VVOS

QualityStocksNewsBreaks – Kingman Minerals Ltd. (TSX.V: KGS) Engages Burgex Inc. to Complete New NI 43-101-Compliant Technical Report

Kingman Minerals (TSX.V: KGS), a Canada-based company engaged in the acquisition, exploration and development of gold and silver properties in North America, recently commissioned Burgex Inc. to produce a new NI 43-101 technical report on its Mohave County assets. An article discussing the company further reads, “Forming part of KGS’s Mohave Project, the historic 167-hectare Rosebud Mine was originally discovered as part of the ‘Gold Rush’ era in the 1880s and was mined extensively until the 1930s. While the most accessible resources have already been extracted, modern mining techniques enable the extraction of difficult lodes safely and cost effectively, giving KGS the ability to tap into the new wealth left behind by previous mining generations. . . . Renewed interest in the Rosebud site by KGS is primarily driven by underground mapping, drilling and sampling of the area conducted between 1984 and 1986 by L.A. Bayrock, PhD, PGeo, on behalf of Stellar Resource Corporation (http://ibn.fm/K2LFf). The proposed drilling site includes eight separate veins and one prominent double vein, which extends from the northwest corner to nearly the southeast corner of the claims block. Written prior to NI 43-101 regulations, the results are not NI 43-101 compliant and require additional underground sampling for verification. KGS has started the process of preparing an NI 43-101-compliant technical report on its Mohave County assets by commissioning the services of Burgex Inc. (http://ibn.fm/9c7fc), a mining consulting services company specializing in the analysis of abandoned mine sites throughout the Western United States.”

To view the full article, visit http://ibn.fm/P73pz

About Kingman Minerals Ltd.
Kingman Minerals is currently engaged in the business of precious-metal mineral exploration for the purpose of acquiring and advancing nongrass-roots mineral properties located in mining friendly jurisdictions of North America. The Mohave Project is located in the Music Mountains in Mohave County, Arizona, and is comprised of 20 lode claims that are inclusive of the past-producing Rosebud Mine. High-grade gold and silver veins were discovered in the area in the 1880s and were mined mainly in the late 1920s and 1930s. Underground development on the Rosebud property included a 400-foot shaft and approximately 2,500 feet of drifts, raises and crosscuts. For more information, visit the company’s website at www.KingmanMinerals.com.

NOTE TO INVESTORS: The latest news and updates relating to KGS are available in the company’s newsroom at http://ibn.fm/KGS

Bullfrog Gold Corp. (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) Details Strategic Growth as Gold Price Increases

-In January 2020, Bullfrog completed a private placement of shares that raised C$2 million to fund drilling of its flagship project with 43-101 compliant gold resource of 525,000 ounces and 110,000 ounces of inferred resources within pit plans
-Company’s project is 125 northwest of Las Vegas and in the area where Barrick Bullfrog gold Inc. produced over 2.3 million ounces of gold between 1989 and 1999
-Bullfrog’s land position is now covers 5,250 acres in the prolific Bullfrog Gold District
-Average gold price is expected to reach by year end an all-time high of $1,970 per troy ounce

Bullfrog Gold (CSE: BFG) (OTCQB: BFGC) (FSE: 11B) President and CEO David Beling detailed the company’s strategic efforts to position for growth over the past decade and discussed development of its flagship Bullfrog Project, as well as company management in an exclusive audio interview with NetworkNewsWire.

“Bullfrog Gold took over an OTC-listed company in mid-2011. The key property that we had at that time is now our flagship property called The Bullfrog Project. We didn’t have any known ounces on it, but we had great potential in an area where Barrick Bullfrog Inc. produced 2.3 million ounces from 1989 to 1999,” Beling said (http://ibn.fm/n1E2s).

In the years since, Bullfrog has expanded its base in Bullfrog Gold District 125 miles northwest of Las Vegas, Nevada. The company has acquired more lands, including an option to purchase key lands from Barrick that contain most of the established resources. Their strategic land ownership and resources have positioned the company for success on the market, particularly with soaring gold prices. According to aggregated statistics, average gold prices worldwide are expected to reach an all-time high of $1,970 per troy ounce this year, from $1,390 per troy ounce in 2019. Analysts expect the average price to stay over $1,900 per ounce over the next few years (http://ibn.fm/90qY9).

Beling underlined that the company is committed to developing its Bullfrog project and adding value, having the necessary capability to take it into production or to complete an M&A or a corporate transaction on the property. “We just recently completed a 25-hole drill program to expand resources, further define expansions of the existing pits and initially test a new, highly prospective exploration target,” he said.
During the interview, Beling also detailed the company’s recent corporate achievements, including a Canadian Stock Exchange listing in September 2019 and closing a C$2 million (US$1.47 million) equity raise in mid-January 2020 to fund its recently completed Bullfrog Project drilling program.

Bullfrog’s corporate backing is just as impressive. The company’s management team has over a century of combined experience in the industry, Beling himself having been in the business for more than 55 years. Chairman and Director Alan Lindsay brings about 42 years of experience, 26 of which are in the mining industry, to the table, while Kjeld Thygesen, independent director, has 48 years of experience in mining research and investment management.

Additionally, approximately 5% of the company is owned by Owl Capital Corp., run by Ron Netolitzky and Dale Wallster. Netolitzky was inducted into the Canadian Mining Hall of Fame in 2015. Wallster and his team discovered what became Hathor’s Roughrider uranium deposit, sold to Rio Tinto for C$650 million (over US$479 million).

At present, the Bullfrog Project has a measured and indicated resource of 525,000,000 ounces of gold and 1.34 million ounces of silver at average grades of 1.02 and 2.61 grams per tonne within pit plans based on a gold price of $1,200 and a cutoff grade of 0.36 g/t. There is also an inferred in-pit resource of 110,000 ounces of gold and 248,000 ounces of silver at similar grades. Barrick conventionally milled and produced over 2.3 million ounces of gold and 2.49 million ounces of silver from three open pits and one underground mine between 1989 and 1999
Project lands cover the Bullfrog and Montgomery-Shoshone pits that the company intends to expand and process using low cost heap leaching methods. Several exploration targets are also planned for drilling.

Since purchasing the initial land position in 2011, Bullfrog optioned 12 patents from Mojave Gold. The company also leased/optioned 28 claims and 6 patents from Barrick that include SE half of Montgomery-Shoshone pit and north third of Bullfrog deposit in 2015 and leased 24 patents, staked 134 claims, and purchased two patents during 2017 and 2018.

For more information, visit the company’s website at www.BullFrogGold.com.

NOTE TO INVESTORS: The latest news and updates relating to BFGC are available in the company’s newsroom at http://ibn.fm/BFGC

QualityStocksNewsBreaks – Why ISW Holdings (ISWH) Is ‘One to Watch’

International Spirits & Wellness Holdings (OTC: ISWH) (“ISW Holdings”) is a top-tier brand incubator operating in the spirits, CBD-infused products, and home health-care markets. A recent article discussing the company reads, “The company’s core mission is to enhance these sectors by implementing innovative services and products ready to meet the demands of a changing world. To that end, ISW Holdings leverages its strategic expertise, resources and innovative software to establish market-leading companies and partnerships, which ensure their success in their chosen industries. This enables the company to return maximum shareholder value with its focus always on its partnerships’ various sector volatility.”

To view the full article, visit http://ibn.fm/5ihOE

About International Spirits & Wellness Holdings
ISWH is a diversified brand incubator with diverse operational interests, including commercial-stage operations in the spirits, CBD, and home health-care markets, and development-stage operations in the logistics and supply chain and renewable energy markets. Based in Nevada, the company’s expertise lies in the strategic development and aggressive early growth of its brands and the establishment of these brands as viable and profitable as an incubator. ISWH has established itself as a health and wellness leader with a focus on reshaping the CBD products and home health-care markets through state-of-the-art technology and execution. The company has also partnered with Bengala Technologies to develop and commercialize enterprise and B2B software technology products targeting the logistics and supply-chain marketplace with VOLUM. For more information, visit the company’s website at www.ISWHoldings.com.

NOTE TO INVESTORS: The latest news and updates relating to ISWH are available in the company’s newsroom at http://ibn.fm/ISWH

QualityStocksNewsBreaks – Plus Products Inc. (CSE: PLUS) (OTCQX: PLPRF) Reports Encouraging Q1 2020 Financial, Operational Results

Plus Products (CSE: PLUS) (OTCQX: PLPRF), a cannabis and hemp-branded products company in the United States, recently reported unaudited financial and operational results for Q1 2020 (http://ibn.fm/pBI4L). An article discussing the company further reads, “‘Our first-quarter financial results paint the picture of a much healthier business than previous quarters,’ he continued. ‘But the work is far from done. In 2020, we are focused on leveraging our core capabilities to create capital-efficient growth through known distribution channels.’ . . . According to the report filed with the Canadian Securities Exchange (‘CSE’), net revenues for the company rose from $3.2 million for Q1 2019 to $4.7 million in Q1 2020 — an impressive 46% increase compared to Q1 2019 net revenues of $3.2 million and a 36% increase over last quarter’s revenue of $3.5 million. Company officials noted the growth came primarily from its California adult-use market, with incremental growth attributed to the Nevada adult-use and national hemp-CBD markets.”

To view the full article, visit http://ibn.fm/w067a

About PLUS
PLUS is a hemp and cannabis food company focused on using nature to bring balance to consumers’ lives. PLUS’s mission is to make cannabis safe and approachable, beginning with high-quality products that deliver consistent consumer experiences. PLUS is headquartered in San Mateo, CA.

For more information, visit the company’s website at www.PlusProducts.com.

NOTE TO INVESTORS: The latest news and updates relating to PLPRF are available in the company’s newsroom at http://ibn.fm/PLPRF